Bronchiectasis Foundation Research
Who are we?
Bronchiectasis Foundation is the leading charity dedicated to research into bronchiectasis disease in the UK. We rely almost wholly on the generous donations of the UK public and we believe that everybody deserves a life free of bronchiectasis disease.
The aim is to facilitate clinical trials and academic research studies in order to improve our understanding of what causes bronchiectasis and to find better, more effective treatment for people with this condition.
Research saves live
Bronchiectasis disease is a silent killer. There are three hundred thousand people in the UK with it right now. Many don’t even know they have it and there is no cure. For decades there has been desperate need for developments in treatment, better information for patients and raising vital public awareness have been needed. As the likelihood of bronchiectasis disease becomes ever greater, our work is more essential than ever.
Supporters are amazing
Thanks to the help from our supporters, we can achieve breakthroughs in the diagnosis, treatment and patient care of those affected by the disease. But much more needs to be done. There are no cures for bronchiectasis disease, only life-extending treatments such as antibiotics and nebulized steroids.
- In 2012, 1,567 people in the UK died from bronchiectasis (0.3 per cent of all deaths and 1.4 per cent of deaths from lung disease), up from 1,150 in 2008.
- Approximately 6,000 people are hospitalized each year
- Around 60% of bronchiectasis diagnoses are made in people aged over 70. Being diagnosed with the condition is more likely as you get older, between the ages of 30 and 70.
- 1 in every 1,000 adults in the UK has bronchiectasis
- Around 210,000 people in the UK were living with bronchiectasis in 2012. This is at least four times higher than the estimate commonly used by the NHS of around 50,000. From 2008 to 2012 prevalence increased by 20%, with the number of people recorded to be living with bronchiectasis going up by 40,000.Other research published this year suggests bronchiectasis prevalence could be in excess of 300,000. More research is required to confirm the number of people living with the condition, and to determine whether bronchiectasis is becoming more common, or being diagnosed more accurately. The increase in prevalence could reflect the reclassification of diseases, and a better understanding of the importance of the condition.
- 50% of patients with COPD also have bronchiectasis